UPDATE 2-Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs By: Reuters: Company News November 21, 2017 at 10:18 AM EST * Starts next phase of key obesity study next year (Adds comment by CEO, Victoza's market share, R&D spending in obesity) Read More >> Related Stocks: Eli Lilly Rogers Corp Vivus Inc